Why you worried about pennies, this stock will hit $1000 by March. There is no competition!
... I'm sorry, just found out that here is competition, from Nissan, Renault, Ford, BMW, Audi, VW, GM, Hyundai, Kia, Toyota, and Mercedes, Honda and Porsche. So, never mind, Tesla is headed down, even if it does manage to close up a few pennies today.
Will this be before or after he builds a Texas factory for Tesla pickups?
For a stock that seems to have been oversold after ER?
The non-bank residential mortgage servicer reported a 8.3% drop sequentially in third quarter revenue to $504.32 million, well short of analysts' expectations of $568.8 million in revenue during the period.
The company did report a 65% increase in net income to $111 million, for a core EPS of 80 cents per diluted share, 7 cents lighter than the company reported during the same period last year.
YRCW is profitable? I think youre rushing a little bit.
Its not going to be profitable for awhile, it lost last quarter on a diluted basis.
and its forecast to get a bit worse short-term:
Avg. Estimate for this quarter -0.26 for next quarter -0.48 for this year -3.28
OVERLAND PARK, Kan. (AP) -- YRC Worldwide Inc. (YRCW) reported earnings of $1.2 million in its third quarter after the market closed on Thursday.
The Overland Park, Kansas-based company said that it had a loss of 3 cents per share on a diluted basis.
The trucking company posted revenue of $1.32 billion in the period.
YRC shares have climbed nearly 5 percent since the beginning of the year. The stock has risen 96 percent in the last 12 months.
Elements of this story were generated by Automated Insights using data from Zacks Investment Research. YRCW stock research report from Zacks.
Using your figures of only a $4B write down ( wow, only $4B ) then the book value would be ~ $8.47
... again, thats using your premise, which wouldnt be totally accurate due to considerations of time, cost of money, etc.
I have heard figures regarding the benefit to company at between $130 to 250 million per year. Wide range, but it depends on a lot of factors and assumptions.
Not sure, was it written down to zero? ... Just like if you depreciate a business vehicle and then sell it for more than you calculated, yes, there is an adjustment.
Restate the depreciation, or show a capitol gain ... IRS is against a free lunch.
Yeah, there werent any protocols for infectious diseases before Ebola?. Hospitals are already stocked for
outbreaks of other diseases. If it gets real bad, they may need replacements, but nothing to justify the hype on stocks associated with Ebola.
Cliffs Natural Resources Inc. (CLF) had its rating cut to "neutral" from "overweight" with a lowered price target of $5 from $13 by analysts at JPMorgan Chase early Monday morning, as the firm cited a lower iron ore price deck from its global commodity team as well as its sum-of-the-parts valuation.
Target is five dollars ( $5 )
Ebola-stoked traders are becoming manic. Seemingly any tiny stock with even a remote chance of an upside due to healthcare's activities to address the risk are now fair game. Shares of thinly-traded micro cap Protalix BioTherapeutics (PLX +30.5%) jump on a 2x surge in volume albeit on turnover of less than 600K.The company has a next-generation recombinant protein expression platform called ProCellEx that utilizes plant (carrot and tobacco) cell culture technology. Traders apparently perceive it has a shot, along with (IBIO +58.5%) at a slice of the U.S. Government's plan to ramp up ZMapp production.